Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis.
Cancer Treat Rev. 2018 May 19;69:1-10
Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
Head Neck. 2018 Apr 17;:
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Cancer Chemother Pharmacol. 2018 Jan 24;:
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
PLoS One. 2017;12(12):e0189848
Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) - A systematic review and meta-analysis.
Cancer Treat Rev. 2017 Dec 06;63:71-78
Comparison of published and unpublished phase I clinical cancer trials: an analysis of the CliniclTrials.gov database.
Invest New Drugs. 2017 Dec 13;:
Breast Cancer Res Treat. 2017 Nov 24;:
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.
JAMA Otolaryngol Head Neck Surg. 2017 Nov 22;:
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Int J Cancer. 2018 Jan 01;142(1):57-65
J Perinatol. 2017 Nov 02;: